The stock broke through a resistance level, corrected as expected and went up nicely last Friday... Keep an eye on it. Huge volume on breakout day. published better than expected reports. Buy - $7.5 First target - $11.3 Second target - $17 Not a recommendation of course... Hi... the only way to trade the stock market... look at my signature below Otherwise it...
The previous resistance is quite stable and flat. Saw a violent reaction on the previous resistance, go long.
Bullish - Needs to clear downward trendline - Formed double bottoms - Building base - Positive FCF - Positive Income - Funds accumulating Entry idea - For members Stop loss depending on entry and risk appetite. But always set meaningful stops. “You don't have to be extreme just consistent” Cheers and happy trading!
the company is excellent and the whoever wanted to sell or forced to sell has already been.. now only up.. the shares offering finished today at $50 ..... long disclaimer
$MRVI is a fairly new IPO and looks like it is in it's first IPO basing process. The proper buy point would be a break out of the highest high with volume. I like early entries so I've set an alert a little lower as it surpasses the most recent high. If the market is good and it alerts me, I'll be looking for a logical entry where I can define my risk. $MRVI...
Looks ready putting in a cup with handle base on the daily chart around the 50 MA. Another day or two with a pullback to $36-$35.75 area could complete the handle. Volume pattern looks strong and indicating a move possible next week. Maravai Lifesciences ClA (MRVI)- PROVIDES PRODUCTS TO DEVELOP DRUG THERAPIES, DIAGNOSTICS, NOVEL VACCINES, AND SUPPORTS RESEARCH...
A 1-2,1-2. T1 is at A=C for a swing equality. T2 target 1.618 extension for a wave 3.
LOOKING FOR THE STOCK TO CONTINUE TO CONSOLIDATE IN THE UPPER CHANNEL AND CONTINUE TO MAKE HIGHER LOWS GOING TOWARDS EARNINGS. A GOOD NEWS CATALYST COULD SEND THE STOCK HIGHER TO BREAK OUT OF THE CHANNEL. IF THE STOCK CONSOLIDATES INTO EARNINGS A GOOD TOP LINE REVENUE AND FORWARD LOOKING STATEMENTS MAY HELP TO BREAK THE CHANNEL. THIS IS NOT FINANCIAL ADVICE...
Long on premise of the strengthening of its IP and pipeline. Likely to establish a new price shelf in the upcoming weeks.
Maravai Lifesciences ClA (MRVI)- PROVIDES PRODUCTS TO DEVELOP DRUG THERAPIES, DIAGNOSTICS, NOVEL VACCINES, AND SUPPORTS RESEARCH ON DISEASES. entry: 34.8 stop: 32.9 target: 37.93